Table 1.
Primary | |
Familial combined hyperlipidemia | |
Familial hypertriglyceridemia | |
Type III hyperlipoproteinemia | |
Chylomicronemia | |
Lipoprotein lipase deficiency | |
Apolipoprotein C-II deficiency | |
Secondary | |
Insulin resistance | |
Diabetes mellitus | |
Obesity | |
Hypothyroidism | |
Alcohol | |
Diet (excessive carbohydrate intake) | |
Nephrotic syndrome | |
Chronic renal failure, uremia | |
Biliary obstruction/cholestasis | |
Acute hepatitis | |
Monoclonal gammopathy | |
Multiple myeloma | |
Systemic lupus erythematosus | |
Stress, Sepsis | |
Pregnancy | |
Ileal bypass surgery | |
Lipodystrophy | |
Glycogen storage disease | |
Drugs | |
Estrogen | |
Isotretinoin | |
Β-blockers | |
Glucocorticoids | |
Cyclosporine | |
Bile acid-binding resins | |
Protease inhibitors | |
Thiazides | |
Tamoxifen |
Modified from Fung and Frohlich[44].